These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1354927

  • 1. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F, Niemegeers CJ, Jansen T, Megens AA, Janssen PA.
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [Abstract] [Full Text] [Related]

  • 2. Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
    Schoch C.
    Ocul Immunol Inflamm; 2005 Feb; 13(1):39-44. PubMed ID: 15804768
    [Abstract] [Full Text] [Related]

  • 3. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 4. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ, Awouters F, Janssen PA.
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [Abstract] [Full Text] [Related]

  • 5. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Apr; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 6. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs.
    Kamei C, Izushi K, Tasaka K.
    J Pharmacobiodyn; 1991 Aug; 14(8):467-73. PubMed ID: 1723098
    [Abstract] [Full Text] [Related]

  • 8. Application of histamine-induced conjunctivitis to the assessment of a topical antihistamine, levocabastine.
    Feinberg G, Stokes TC.
    Int Arch Allergy Appl Immunol; 1987 Aug; 82(3-4):537-8. PubMed ID: 2883131
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
    Akiyoshi M, Shigeoka T, Torii S, Maki E, Enomoto S, Takahashi H, Hirano F.
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):175-84. PubMed ID: 11915520
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H.
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [Abstract] [Full Text] [Related]

  • 12. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H, Suda H, Kitagaki K, Goto S, Miura T, Koda A.
    Arch Int Pharmacodyn Ther; 1990 Jul; 307():172-82. PubMed ID: 1710442
    [Abstract] [Full Text] [Related]

  • 13. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S, McTavish D.
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [Abstract] [Full Text] [Related]

  • 14. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(6):397-406. PubMed ID: 8892269
    [Abstract] [Full Text] [Related]

  • 15. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A, Schaumann W, Wilhelms OH.
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [Abstract] [Full Text] [Related]

  • 16. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL, Goa KL.
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [Abstract] [Full Text] [Related]

  • 17. Effects of AHR-5333, a new potential antiallergy compound, in in vivo models of immediate hypersensitivity.
    Yanni JM, Foxwell MH.
    Int Arch Allergy Appl Immunol; 1988 Feb; 85(4):428-33. PubMed ID: 2895747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selective effect of levocabastine on histamine receptor and histamine release from human leukocytes and guinea pig isolated tissue.
    Garrelds IM, de Graaf-in't Veld T, van Toorenenbergen AW, van Wijk RG, Boegheim JP, Saxena PR, Zijlstra FJ.
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):327-34. PubMed ID: 8612114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.